Logo
ScannerX
Market Intelligence
Home Fundamentals Futures Sector Trend Daily Sector Weekly Industry Daily Industry Industry Relative Strength Equity Rank Metrics Moving Average Correlation Charts Guide
Login
📰 Latest News
Oct. 20, 2026, 8 p.m. Viridian Therapeutics to Report Third Quarter 2026 Financial Results on November 4, 2026
Sector
Healthcare
Industry
Biotechnology
Market Cap
2.61
Volume
1,893,646
P/E
nan
ROE
-65.74
52W High
34.29
52W Low
13.18
Price Overview
Open
22.5
High
23.29
Low
22.5
Intraday Range
3.51%
20D Avg Volume
2,117,962
Distance From 52W High
-32.9%
Technical Levels
20 SMA
19.65
50 SMA
21.59
200 SMA
22.03
Last 7 Trading Days
Date Open High Low Close Volume % Change Gap % Range %
2026-10-21 22.5 23.29 22.5 23.01 1,893,646 ▲ 2.59% 0.31% 3.51%
2026-10-20 21.1 22.68 20.85 22.43 1,974,600 ▲ 7.84% 1.44% 8.78%
2026-10-19 19.23 20.88 19.07 20.8 2,576,100 ▲ 9.3% 1.05% 9.47%
2026-10-16 19.67 19.78 18.94 19.03 2,457,300 ▼ -2.71% 0.56% 4.44%
2026-10-15 18.69 19.78 18.53 19.56 2,167,900 ▲ 6.42% 1.69% 6.72%
2026-10-14 18.19 18.75 18.01 18.38 3,732,900 ▲ 0.88% -0.16% 4.08%
2026-10-13 18.04 18.33 17.96 18.22 2,124,100 ▼ nan% nan% 2.06%
Fundamentals
Business
Sector Healthcare
Industry Biotechnology
Market Cap 2.61B
Float Adj MCap 2.32B
Valuation
P/E nan
Forward P/E -8.35
P/S 2294.77
P/B 4.62
PEG nan
Quality Metrics
ROE -65.74%
ROA -30.16%
Gross Margin 0.0%
Operating Margin -44460.56%
Profit Margin 0.0%
Trading Metrics
Relative Volume 1.07
Average Volume 1.8M
Beta 1.1
Short Float 16.43%
Latest Q/Q Growth
Revenue 101.42%
Profit -21.18%
Operating Income -8.69%
EPS -16.67%
Quarterly History
Revenue Qtrs 0.0, 0.0, 0.0, 0.07
Profit Qtrs -0.13, -0.1, -0.12, -0.03
Operating Qtrs -0.13, -0.12, -0.12, -0.04
EPS Qtrs -1.05, -0.9, -1.08, -0.34